Why AI coding agents aren’t production-ready: Brittle context windows, broken refactors ...

This article will examine the practical pitfalls and limitations observed when engineers use modern coding agents for real ...
appliedclinicaltrialsonline

How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies

In this Q&A, John Kirk, principal regulatory strategist at Veristat, explains how the FDA’s Commissioner’s National Priority Voucher (CNPV) Program is accelerating operational timelines, tightening ...